Facebook
Linkedin
Mail
Twitter
Youtube
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscriptions
Subscribe here
Manage your subscriptions
Search
Facebook
Linkedin
Mail
Twitter
Youtube
Cardiovascular News
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscriptions
Subscribe here
Manage your subscriptions
Tag: EBBINGHAUS
Evolocumab significantly reduces risk of cardiovascular events
3rd February 2017
The FOURIER trial evaluating whether evolocumab (Repatha, Amgen) reduces the risk of cardiovascu...